High frequency of IL-4 producing helper T lymphocytes associated with a reduced incidence of heart allograft rejection

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Van Hoffen, E ^a   Polen, E ^a   Robertus Teunissen, M ^a   De Jonge, N ^a   Lahpor, J R ^a   Gmelig Meyling, F H J ^a   De Weger, R A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Heart transplantation; Interleukin 2; Interleukin 4; Limiting dilution analysis; Nonresponsiveness; pHTL

Indexed keywords

BIOLOGICAL MARKER; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4;

ALLOTRANSPLANTATION; ARTICLE; BLOOD; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; DONOR; GRAFT REJECTION; HEART TRANSPLANTATION; HELPER CELL; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; INCIDENCE; TIME;

BIOLOGICAL MARKERS; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; INCIDENCE; INTERLEUKIN-2; INTERLEUKIN-4; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0000262691     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02023.x     Document Type: Article

References (38)

1. Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 9: 587-593
2. Bouma GJ, Van der Meer-Prins EMW, Van der Woude FJ, Van Rood JJ, Claas FHJ (1995) Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival. Transplantation 59: 969-976
3. + T cell regulation during the induction phase of the response. Eur J Immunol 25: 2643-2649
4. Cattell EL, Cunningham AC, Bal W, Taylor RMR, Dark JH, Kirby JA (1994) Limiting dilution analysis: quantification of IL-2 producing allospecific lymphocytes after renal and cardiac transplantation. Transplant Immunol 2: 300-307
5. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S (1996) Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 62: 1200-1206
6. Davies JD, Martin G, Phillips J, Marshall SE, Cobbold SP, Waldmann H (1996) T cell regulation in adult transplantation tolerance. J Immunol 157: 529-533
7. Deacock S, Schwarer A, Batchelor R, Goldman J, Lechler R (1992) A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humans. J Immunol Methods 147: 83-92
8. Gracie JA, Bolton EM, Porteous C, Bradley JA (1990) T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 172: 1547-1557
9. Grimm PC, McKenna RM, Gospodarek EM, Jeffery JR, Rush DN (1995) Low frequency of infiltrating cells intensely expressing T cell cytokine mRNA in human renal allograft rejection. Transplantation 59: 579-584
10. Hancock WW, Sayegh MH, Zheng X-G, Peach R, Linsley PS, Turka LA (1996) Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 93: 13967-13967
11. Hosenpud JD, Edwards EB, Lin H-M, Daily OP (1996) Influence of HLA matching on thoracic transplant outcomes. An analysis from the UNOS/ ISHLT thoracic registry. Circulation 94: 170-174
12. Hsieh C-S, Heimberger AB, Gold JS, O'Garra A, Murphy KM (1992) Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T cell-receptor transgenic system. Proc Natl Acad Sci USA 89: 6065-6069
13. Hu HZ, Robertus M, De Jonge N, Gmelig-Meyling FH, Van Der Meulen A, Schuurman H-J, Doornewaard H, van Prooijen HC, De Weger RA (1994) Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of allografted heart recipients. Transplantation 58: 1263-1268
14. Hu-Li J, Ohara J, Watson C, Tsang W, Paul WE (1989) Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol 142: 800-807
15. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJC, Melzer J, Garovy MR, Roberts JP, Ascher NL, Martinez OM (1992) Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 53: 151-156
16. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94: 8789-8794
17. Lakkis FD, Konieczny BT, Saleem S, Baddoura FK, Linsley PS, Alexander DZ, Lowry RP, Pearson TC, Larsen CP (1997) Blocking the CD28-B7T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 158: 2443-2448
18. Lin H, Wei R-Q, Goodman RE, Bolling SF (1997) CD28 blockade alters cytokine mRNA profiles in cardiac transplantation. Surgery 122: 129-137
19. O'Connell PJ, Pacheco-Silva A, Nickerson PW, Muggia RA, Bastos M, Kelley VR, Strom TB (1993) Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 150: 1093-1104
20. Rao A (1995) NFATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J Leukoc Biol 57: 536-542
21. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25 [Suppl 2]:74-78
22. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ (1996) Kinetics of induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 61: 1642-1647
23. + T cells in the induction of tolerance to class I molecules. Transplantation 61: 1532-1538
24. Salgame P, Abrams JS, Clayberger C (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279
25. Schuurman H-J, Gmelig-Meyling FHJ, Wijngaard PLJ, Van der Meulen A, Slootweg PJ, Jambroes G (1989) Lymphocyte status in endomyocardial biopsies and blood after heart transplantation. J Pathol 159: 197-203
26. + T cell-mediated graft rejection. Eur J Immunol 27: 1663-1670
27. + T cells. Annu Rev Immunol 12: 635-673
28. + T cells from T cell receptor transgenic mice. J Exp Med 176: 1091-1098
29. Sharrock CEM, Kaminski E, Man S (1990) Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 11: 281-286
30. Song Z, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ (1996) Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 156: 424-429
31. Strijbosch LWG, Buurman WA, Does RJMM, Zinken PH, Groenewegen G (1987) Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods 97: 133-140
32. Takeuchi T, Lowry RP, Konieczny B (1992) Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53: 1281-1294
33. Taswell C (1984) Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model. J Immunol Methods 72: 29-40
34. Turner D, Grant SCD, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV (1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64: 776-779
35. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A (1992) Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 175: 637-646
36. Van Hoffen E, Van Wichen D, Stuij I, De Jonge N, Klöpping C, Lahpor J, Van Den Tweel J, Gmelig-Meyling F, De Weger R (1996) In situ expression of cytokines in human heart allografts. Am J Pathol 149: 1991-2003
37. Wijngaard PLJ, Schuurman H-J, Gmelig Meyling FHJ, Jambroes G, Borleffs JC (1992) Transplantation tolerance in heart transplant recipients as demonstrated by unresponsiveness in cell-mediated lympholysis. Hum Immunol 34: 167-172
38. Zanker B, Jooss-Rüdiger J, Franz H-E, Wagner H, Kabelitz D (1993) Evidence that functional deletion of donor-reactive T lymphocytes in kidney allograft recipients can occur at the level of cytotoxic T cells, IL-2-producing T cells, or both. Transplantation 56: 628-632